Business Standard

Parabolic Drugs reports standalone net loss of Rs 39.18 crore in the December 2014 quarter

Image

Capital Market

Sales decline 60.30% to Rs 42.90 crore

Net Loss of Parabolic Drugs reported to Rs 39.18 crore in the quarter ended December 2014 as against net loss of Rs 24.46 crore during the previous quarter ended December 2013. Sales declined 60.30% to Rs 42.90 crore in the quarter ended December 2014 as against Rs 108.07 crore during the previous quarter ended December 2013. ParticularsQuarter EndedDec. 2014Dec. 2013% Var.Sales42.90108.07 -60 OPM %-7.041.44 -PBDT-21.99-18.37 -20 PBT-39.18-35.40 -11 NP-39.18-24.46 -60

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 14 2015 | 4:43 PM IST

Explore News